Iron Absorption From GDS Capsules

Not Applicable

Completed

• Conditions: Iron Deficiency

• Registration Number: NCT01874496
• Lead Sponsor: Swiss Federal Institute of Technology

Brief Summary

Slow release iron capsules have been designed based on the gastric delivery system. Iron absorption from those capsules administered with and without meals will be measured using stable iron isotopes.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05
• Study First Submitted: 2013-05-13
• Primary Completion: 2013-06
• Study First Submitted QC: 2013-06-06
• Study First Posted: 2013-06-11
• Study Completion: 2013-08
• Status Verified: 2013-09
• Last Update Submitted: 2013-09-12
• Last Update Posted: 2013-09-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 4

Inclusion Criteria

• female,
• age 18-50 years,
• max. body weight 65 kg,
• serum ferritin < 35µg/l

Exclusion Criteria

• pregnancy,
• lactation,
• regular intake of medication,
• blood donation or significant blood losses over the past 4 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
fractional iron absorption	2, 4, 6, and 8 weeks

Secondary Outcome Measures

Name	Time	Method
serum isotope appearance	day 1, 15, 29 and 33

Trial Locations

Locations (1)

Human Nutrition Laboratory, ETH Zurich; 🇨🇭 Zurich, Switzerland